Aegera Therapeutics
Montréal
About Aegera Therapeutics
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.6M
- Funding stage: M&A
- Last round: Debt Financing (Sep 2009)
- Website: aegera.com
- Phone: (514) 288-553
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aegera-therapeutics-2930375 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.